Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A novel means to demonstrate early efficacy of a product in systemic lupus erythematosus.

× No keyword cloud information.

22 in total

1. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus.

Authors: Matthew D Linnik; Jay Z Hu; Kenneth R Heilbrunn; Vibeke Strand; Frank L Hurley; Tenshang Joh
Journal: Arthritis Rheum Date: 2005-04

2. Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.

Authors: Kenneth C Kalunian; John C Davis; Joan T Merrill; Mark C Totoritis; David Wofsy
Journal: Arthritis Rheum Date: 2002-12

Review 3. Biologic therapies in rheumatology: lessons learned, future directions.

Authors: Vibeke Strand; Robert Kimberly; John D Isaacs
Journal: Nat Rev Drug Discov Date: 2007-01 Impact factor: 84.694

4. Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritis.

Authors: K C Tse; C S O Tang; W I Lio; M F Lam; T M Chan
Journal: Lupus Date: 2006 Impact factor: 2.911

5. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

Authors: Kyriakos A Kirou; Christina Lee; Sandhya George; Kyriakos Louca; Margaret G E Peterson; Mary K Crow
Journal: Arthritis Rheum Date: 2005-05

Review 6. Lessons learned from clinical trials in SLE.

Authors: Vibeke Strand
Journal: Autoimmun Rev Date: 2006-08-28 Impact factor: 9.754

7. LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study.

Authors: Donato Alarcón-Segovia; James A Tumlin; Richard A Furie; James D McKay; Mario H Cardiel; Vibeke Strand; Robert G Bagin; Matthew D Linnik; Bonnie Hepburn
Journal: Arthritis Rheum Date: 2003-02

8. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.

Authors: A J Swaak; J Groenwold; W Bronsveld
Journal: Ann Rheum Dis Date: 1986-05 Impact factor: 19.103

Review 9. Health-related quality of life in patients with systemic lupus erythematosus: an update.

Authors: Julian Thumboo; Vibeke Strand
Journal: Ann Acad Med Singapore Date: 2007-02 Impact factor: 2.473

10. Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies.

Authors: Vibeke Strand; Bruce Crawford
Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2005-06 Impact factor: 2.217

1 in total

Review 1. Why can't we find a new treatment for SLE?

Authors: Robert Eisenberg
Journal: J Autoimmun Date: 2009-03-28 Impact factor: 7.094

1 in total